In this regard, it should be kept in mind that, although AQP4 is expressed on astrocytes throughout the central nervous system (CNS), AQP4-expressing spinal cord astrocytes are by far the main targets of anti-AQP4 antibodies in NMO patients. The gene discussed is AQP4; the disease is neuromyelitis optica.